Inflammatory biomarker profile in children with cystic fibrosis: preliminary study

被引:5
作者
Slobodianik, N. H. [1 ]
Feliu, M. S. [1 ]
Perris, P. [1 ]
Barbeito, S. [2 ]
Strasnoy, I. [2 ]
Franchello, A. [2 ]
Ferraro, M. [2 ]
机构
[1] Univ Buenos Aires, Sch Pharm & Biochem, Dept Nutr & Food Sci, RA-1053 Buenos Aires, DF, Argentina
[2] Pedro Elizalde Hosp, Nutr Serv, Buenos Aires, DF, Argentina
关键词
Cystic fibrosis; Children; Biochemical parameters; Proteins; Total antioxidant capacity; ANTIOXIDANT CAPACITY;
D O I
10.1017/S0029665110001771
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The aim of this preliminary study was to determine specific proteins, related to inflammation process and nutritional status as well as to total antioxidant capacity, in children suffering from cystic fibrosis (CF). The study was performed on 17 nonhospitalized children (12 boys and 5 girls) with CF aged 3 months to 10 years, who were assisted at the Nutrition Service from Pedro de Elizalde Hospital. Transferrin, transthyretin, ceruloplasmin (Cp), haptoglobin, C-reactive protein (CRP) and fibrinogen were measured by single radial immunodiffusion techniques. Total antioxidant capacity (TAC) was determined by a decolorization assay. Statistical analyses were performed by the Student's t test. Transferrin and transthyretin values were lower in CF patients in comparison with data obtained from healthy children (reference group, RG). The decreased transferrin concentration and the tendency towards low plasma transthyretin values suggested an abnormal nutritional, status. However, higher Cp and haptoglobin levels were shown in patients than in RG. The fact that 23 and 50% of patients exceeded the desirable values for fibrinogen (<285.0 mg/dl) and CRP (<0-2 mg/dl), respectively, should be highlighted. The TAC (mm; Trolox equivalents) was shown to be lower in the CF group than in RG. The diminished TAC concomitant with an increased plasma Cp concentration would exacerbate the inflammatory status and could explain the depression of the immune system. These preliminary results could explain the need to include biochemical and functional parameters in the early nutritional status evaluation in CF patients in order to use appropriate nutritional and pharmacological therapies and consequently to improve their survival and quality of life.
引用
收藏
页码:354 / 356
页数:3
相关论文
共 23 条
  • [1] Anton Dana-Teodora, 2006, Rev Med Chir Soc Med Nat Iasi, V110, P801
  • [2] Antioxidants in cystic fibrosis - Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003
    Cantin, Andre M.
    White, Terry B.
    Cross, Carroll E.
    Forman, Henry Jay
    Sokol, Ronald J.
    Borowitz, Drucy
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (01) : 15 - 31
  • [3] Cystic fibrosis: Nutritional consequences and management
    Dodge, John A.
    Turck, Dominique
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (03) : 531 - 546
  • [4] EMMETT M, 1987, P SOC EXP BIOL MED, V184, P74
  • [5] FELIU M, 1992, ACTA BIOQUIM CLIN L, V26, P319
  • [6] FELIU MS, 1992, BIOLINE, V6, P6
  • [7] Ceruloplasmin and cardiovascular disease
    Fox, PL
    Mazumder, B
    Ehrenwald, E
    Mukhopadhyay, CK
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) : 1735 - 1744
  • [8] Nutrition and growth in cystic fibrosis
    Hankard, R
    Munck, A
    Navarro, J
    [J]. HORMONE RESEARCH, 2002, 58 : 16 - 20
  • [9] TRANSTHYRETIN (PREALBUMIN) IN HEALTH AND DISEASE - NUTRITIONAL IMPLICATIONS
    INGENBLEEK, Y
    YOUNG, V
    [J]. ANNUAL REVIEW OF NUTRITION, 1994, 14 : 495 - 533
  • [10] Nutritional challenges of infants with cystic fibrosis
    Koletzko, S
    Reinhardt, D
    [J]. EARLY HUMAN DEVELOPMENT, 2001, 65 : S53 - S61